KENDALL CAPITAL MANAGEMENT – AstraZeneca PLC Transaction History
KENDALL CAPITAL MANAGEMENT portfolio value:
$202,000
portfolio value
KENDALL CAPITAL MANAGEMENT quarter portfolio value change:
-17.00%
quarter
AstraZeneca PLC 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -2.64% | -100 shares | -48K | $54.84 | 3.69K |
| Q2 2022 | share | 0.00% | 0 shares | -1K | $66.07 | 3.79K | |
| Q1 2022 | share | Decrease | -2.77% | -108 shares | 24K | $66.34 | 3.79K |
| Q4 2021 | share | Decrease | -2.31% | -92 shares | -13K | $58.47 | 3.89K |
| Q3 2021 | share | Increase | +2.73% | 106 shares | 7K | $60.06 | 3.99K |
| Q2 2021 | share | Increase | 0.00% | 3.88K shares | 233K | $59.44 | 3.88K |
| Q4 2020 | share | Decrease | -100.00% | -3.88K shares | -213K | $48.68 | 0 |
| Q3 2020 | share | Decrease | -24.34% | -1.25K shares | -59K | $53.37 | 3.88K |
| Q2 2020 | share | 0.00% | 0 shares | 43K | $51.1 | 5.13K | |
| Q1 2020 | share | 0.00% | 0 shares | -27K | $43.15 | 5.13K | |
| Q4 2019 | share | Decrease | -4.11% | -220 shares | 17K | $47.17 | 5.13K |
| Q3 2019 | share | Decrease | -10.45% | -625 shares | -8K | $42.17 | 5.35K |
| Q2 2019 | share | Decrease | -4.55% | -285 shares | -6K | $38.66 | 5.98K |
| Q1 2019 | share | Decrease | -5.29% | -350 shares | 2K | $37.87 | 6.26K |
| Q4 2018 | share | Decrease | -6.37% | -450 shares | -29K | $34.78 | 6.61K |
| Q3 2018 | share | Decrease | -33.76% | -3.6K shares | -94K | $36.23 | 7.06K |
| Q2 2018 | share | Decrease | -32.56% | -5.15K shares | -179K | $31.79 | 10.66K |
| Q1 2018 | share | Decrease | -1.25% | -200 shares | -3K | $31.66 | 15.81K |
| Q4 2017 | share | Increase | 0.00% | 16.01K shares | 556K | $30.56 | 16.01K |